Trammell, S.A., et al., Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk. J Nutr, 2016. 146(5): p. 957-63.
Trammell, S.A., et al., Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun, 2016. 7: p. 12948.
Bieganowski, P. and C. Brenner, Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell, 2004. 117(4): p. 495-502.
Canto, C., et al., The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab, 2012. 15(6): p. 838-47.
Ratajczak, J., et al., NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun, 2016. 7: p. 13103.
Imai, S. and L. Guarente, NAD+ and sirtuins in aging and disease. Trends Cell Biol, 2014. 24(8): p. 464-71.
Imai, S., Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des, 2009. 15(1): p. 20-8.
Revollo, J.R., A.A. Grimm, and S. Imai, The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem, 2004. 279(49): p. 50754-63.
Chini, C.C., M.G. Tarrago, and E.N. Chini, NAD and the aging process: Role in life, death and everything in between. Mol Cell Endocrinol, 2016.
Braidy, N., et al., Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One, 2011. 6(4): p. e19194.
Gomes, A.P., et al., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013. 155(7): p. 1624-38.
Massudi, H., et al., Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 2012. 7(7): p. e42357.
Zhu, X.H., et al., In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A, 2015. 112(9): p. 2876-81.
Canto, C., K.J. Menzies, and J. Auwerx, NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab, 2015. 22(1): p. 31-53.
Ziegler, M. and M. Niere, NAD+ surfaces again. Biochem J, 2004. 382(Pt 3): p. e5-6.
Belenky, P., K.L. Bogan, and C. Brenner, NAD+ metabolism in health and disease. Trends Biochem Sci, 2007. 32(1): p. 12-9.
Boutant, M. and C. Canto, SIRT1 metabolic actions: Integrating recent advances from mouse models. Mol Metab, 2014. 3(1): p. 5-18.
Mouchiroud, L., et al., The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell, 2013. 154(2): p. 430-41.
Kanfi, Y., et al., The sirtuin SIRT6 regulates lifespan in male mice. Nature, 2012. 483(7388): p. 218-21.
Chang, H.C. and L. Guarente, SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab, 2014. 25(3): p. 138-45.